--- title: "Earnings Scheduled For March 30, 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/281012742.md" description: "Earnings are scheduled for March 30, 2026, with several companies reporting their quarterly results. Notable earnings estimates include Liberty All Star Equity (NYSE:USA) at $0.05 per share, Americas Gold And Silver (AMEX:USAS) at $0.04 per share, and Phreesia (NYSE:PHR) at $0.23 per share. Companies like CBAK Energy Tech (NASDAQ:CBAT) and Rezolve AI (NASDAQ:RZLV) are expected to report losses. Other companies reporting include PAVmed (NASDAQ:PAVM) and Virgin Galactic Holdings (NYSE:SPCE), both projected to report significant losses. The article is generated by Benzinga's automated content engine and reviewed by an editor." datetime: "2026-03-30T11:11:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281012742.md) - [en](https://longbridge.com/en/news/281012742.md) - [zh-HK](https://longbridge.com/zh-HK/news/281012742.md) --- # Earnings Scheduled For March 30, 2026 ### Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is estimated to report quarterly earnings at $0.05 per share on revenue of $65.27 million. • Americas Gold And Silver (AMEX:USAS) is estimated to report quarterly earnings at $0.04 per share on revenue of $65.27 million. • Fermi (NASDAQ:FRMI) is expected to report earnings for its fourth quarter. • CBAK Energy Tech (NASDAQ:CBAT) is expected to report quarterly loss at $0.03 per share on revenue of $64.57 million. • Pulsenmore (NASDAQ:PLSM) is expected to report earnings for its fourth quarter. • PDS Biotechnology (NASDAQ:PDSB) is expected to report earnings for its fourth quarter. • Bicara Therapeutics (NASDAQ:BCAX) is estimated to report earnings for its fourth quarter. • Rezolve AI (NASDAQ:RZLV) is projected to report quarterly loss at $0.24 per share on revenue of $40.98 million. • Nano Labs (NASDAQ:NA) is likely to report earnings for its Fiscal Year 2025. • Terrestrial Energy (NASDAQ:IMSR) is likely to report earnings for its fourth quarter. • PAVmed (NASDAQ:PAVM) is likely to report quarterly loss at $4.62 per share on revenue of $25 thousand. • Neumora Therapeutics (NASDAQ:NMRA) is estimated to report earnings for its fourth quarter. • Sigma Lithium (NASDAQ:SGML) is expected to report quarterly loss at $0.05 per share on revenue of $45.68 million. ### Companies Reporting After The Bell • Dawson Geophysical (NASDAQ:DWSN) is expected to report earnings for its fourth quarter. • Phreesia (NYSE:PHR) is projected to report quarterly earnings at $0.23 per share on revenue of $126.52 million. • CVD Equipment (NASDAQ:CVV) is likely to report earnings for its fourth quarter. • AirJoule Technologies (NASDAQ:AIRJ) is projected to report earnings for its fourth quarter. • Spruce Power Holding (NYSE:SPRU) is likely to report earnings for its fourth quarter. • Solana (NASDAQ:HSDT) is likely to report quarterly loss at $26.50 per share on revenue of $140 thousand. • Innventure (NASDAQ:INV) is likely to report quarterly loss at $0.34 per share on revenue of $2.01 million. • INmune Bio (NASDAQ:INMB) is estimated to report earnings for its fourth quarter. • Lantern Pharma (NASDAQ:LTRN) is likely to report earnings for its fourth quarter. • Intellinetics (AMEX:INLX) is projected to report quarterly loss at $0.08 per share on revenue of $4.15 million. • Off The Hook YS (AMEX:OTH) is expected to report earnings for its first quarter. • DiaMedica Therapeutics (NASDAQ:DMAC) is likely to report earnings for its fourth quarter. • Oxbridge Re Holdings (NASDAQ:OXBR) is expected to report quarterly loss at $0.01 per share on revenue of $662 thousand. • Standard Lithium (AMEX:SLI) is estimated to report earnings for its fourth quarter. • RenovoRx (NASDAQ:RNXT) is projected to report quarterly loss at $0.08 per share on revenue of $451 thousand. • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.02 per share on revenue of $38.15 million. • Arko Petroleum (NASDAQ:APC) is projected to report quarterly earnings at $0.20 per share on revenue of $1.31 billion. • HireQuest (NASDAQ:HQI) is expected to report quarterly earnings at $0.13 per share on revenue of $7.37 million. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $1.66 per share on revenue of $6.00 million. • ZSPACE (NASDAQ:ZSPC) is expected to report quarterly loss at $0.14 per share on revenue of $6.20 million. • Progress Software (NASDAQ:PRGS) is estimated to report quarterly earnings at $1.41 per share on revenue of $246.04 million. • Fathom Holdings (NASDAQ:FTHM) is estimated to report quarterly loss at $0.12 per share on revenue of $97.55 million. • Lulus Fashion Lounge (NASDAQ:LVLU) is expected to report earnings for its fourth quarter. • Virgin Galactic Hldgs (NYSE:SPCE) is expected to report quarterly loss at $1.09 per share on revenue of $379 thousand. • DeFi Development (NASDAQ:DFDV) is expected to report quarterly loss at $0.07 per share on revenue of $4.10 million. • Beeline Holdings (NASDAQ:BLNE) is projected to report quarterly loss at $0.31 per share on revenue of $2.71 million. This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [USAS.US](https://longbridge.com/en/quote/USAS.US.md) - [RZLV.US](https://longbridge.com/en/quote/RZLV.US.md) - [PAVM.US](https://longbridge.com/en/quote/PAVM.US.md) - [RZLVW.US](https://longbridge.com/en/quote/RZLVW.US.md) - [USA.US](https://longbridge.com/en/quote/USA.US.md) - [CBAT.US](https://longbridge.com/en/quote/CBAT.US.md) - [SPCE.US](https://longbridge.com/en/quote/SPCE.US.md) - [PHR.US](https://longbridge.com/en/quote/PHR.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) ## Related News & Research - [Analyst Maintains Hold on Virgin Galactic Amid Wider-Than-Expected Losses but Improving Cash Usage and Ongoing Test Progress](https://longbridge.com/en/news/286577979.md) - [PAVmed Reports Q1 2026 Results and Business Update](https://longbridge.com/en/news/286567652.md) - [Virgin Galactic (SPCE) Reports Q1 Earnings This Week. This is What Shareholders Should Expect.](https://longbridge.com/en/news/285974708.md) - [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md) - [Lifeward Delays Quarterly Report Amid Deal Accounting](https://longbridge.com/en/news/286586728.md)